Skip to Main Content
Welcome to the Marketplace

Go to Main Navigation


Myrcludex B

BOC Sciences

Thumbnail image


Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide.


  • Aliases: MyrB; Myrcludex-B; Hepatera; MYR Pharma; Vision7; Bulevirtide
  • Cas Number: 2012558-47-1
  • Molecular Weight: 5398.95
  • Molecular Formula: C248H355N65O72